scholarly journals Exercise During the First Trimester of Pregnancy and the Risks of Abnormal Screening and Gestational Diabetes Mellitus

2020 ◽  
Author(s):  
Samantha F. Ehrlich ◽  
Assiamira Ferrara ◽  
Monique M. Hedderson ◽  
Juanran Feng ◽  
Romain Neugebauer

<b>Objective:</b> To estimate the effects of exercise during the first trimester on the risks of abnormal screening and gestational diabetes mellitus (GDM). <p><b>Research Design and Methods:</b> Data come from PETALS, a prospectively followed pregnancy cohort (n= 2,246, <a>79% minorities</a>) receiving care at Kaiser Permanente Northern California. A Pregnancy Physical Activity Questionnaire was used to assess exercise. Glucose testing results for screening and diagnostic tests were obtained from electronic health records. Inverse probability of treatment weighting and Targeted Maximum Likelihood with data-adaptive estimation (machine learning) of propensity scores and outcome regressions were used to obtain causal risk differences adjusted for potential confounders, including prepregnancy BMI, exercise before pregnancy, and gestational weight gain. Exercise was dichotomized at: 1) the cohort’s 75<sup>th</sup> percentile for moderate to vigorous intensity exercise (≥ 13.2 MET hours per week, approximately ≥ 264 minutes per week of moderate exercise), 2) current recommendations (≥ 7.5 MET hours per week, or ≥ 150 minutes per week of moderate exercise), and 3) any vigorous exercise. </p> <p><b>Results</b>: Overall, 24.3% and 6.5% had abnormal screening and GDM, respectively. Exercise meeting or exceeding the 75<sup>th</sup> percentile decreased the risks of abnormal screening and GDM, by 4.8 (95% CI 1.1, 8.5) and 2.1 (0.2, 4.1) fewer cases per 100, respectively, in adjusted analyses. </p> <p><b>Conclusions</b>: Exercise reduces the risks of abnormal screening and GDM but the amount needed to achieve these risk reductions is likely higher than current recommendations. Future interventions may consider promoting ≥ 38 minutes per day of moderate intensity exercise to prevent GDM. </p>

2020 ◽  
Author(s):  
Samantha F. Ehrlich ◽  
Assiamira Ferrara ◽  
Monique M. Hedderson ◽  
Juanran Feng ◽  
Romain Neugebauer

<b>Objective:</b> To estimate the effects of exercise during the first trimester on the risks of abnormal screening and gestational diabetes mellitus (GDM). <p><b>Research Design and Methods:</b> Data come from PETALS, a prospectively followed pregnancy cohort (n= 2,246, <a>79% minorities</a>) receiving care at Kaiser Permanente Northern California. A Pregnancy Physical Activity Questionnaire was used to assess exercise. Glucose testing results for screening and diagnostic tests were obtained from electronic health records. Inverse probability of treatment weighting and Targeted Maximum Likelihood with data-adaptive estimation (machine learning) of propensity scores and outcome regressions were used to obtain causal risk differences adjusted for potential confounders, including prepregnancy BMI, exercise before pregnancy, and gestational weight gain. Exercise was dichotomized at: 1) the cohort’s 75<sup>th</sup> percentile for moderate to vigorous intensity exercise (≥ 13.2 MET hours per week, approximately ≥ 264 minutes per week of moderate exercise), 2) current recommendations (≥ 7.5 MET hours per week, or ≥ 150 minutes per week of moderate exercise), and 3) any vigorous exercise. </p> <p><b>Results</b>: Overall, 24.3% and 6.5% had abnormal screening and GDM, respectively. Exercise meeting or exceeding the 75<sup>th</sup> percentile decreased the risks of abnormal screening and GDM, by 4.8 (95% CI 1.1, 8.5) and 2.1 (0.2, 4.1) fewer cases per 100, respectively, in adjusted analyses. </p> <p><b>Conclusions</b>: Exercise reduces the risks of abnormal screening and GDM but the amount needed to achieve these risk reductions is likely higher than current recommendations. Future interventions may consider promoting ≥ 38 minutes per day of moderate intensity exercise to prevent GDM. </p>


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 86-LB
Author(s):  
TIANGE SUN ◽  
FANHUA MENG ◽  
RUI ZHANG ◽  
ZHIYAN YU ◽  
SHUFEI ZANG ◽  
...  

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Chuyao Jin ◽  
Lizi Lin ◽  
Na Han ◽  
Zhiling Zhao ◽  
Zheng Liu ◽  
...  

Abstract Background To assess the association between plasma retinol-binding protein 4 (RBP4) levels both in the first trimester and second trimester and risk of gestational diabetes mellitus (GDM). Methods Plasma RBP4 levels and insulin were measured among 135 GDM cases and 135 controls nested within the Peking University Birth Cohort in Tongzhou. Multivariable linear regression analysis was conducted to assess the influence of RBP4 levels on insulin resistance. Conditional logistic regression models were used to compute the odds ratio (OR) and 95% confidence interval (CI) between RBP4 levels and risk of GDM. Results The GDM cases had significantly higher levels of RBP4 in the first trimester than controls (medians: 18.0 μg/L vs 14.4 μg/L; P < 0.05). Plasma RBP4 concentrations in the first and second trimester were associated with fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR), and the quantitative insulin sensitivity check index (QUICKI) in the second trimester (all P < 0.001). With adjustment for diet, physical activity, and other risk factors for GDM, the risk of GDM increased with every 1-log μg/L increment of RBP4 levels, and the OR (95% CI) was 3.12 (1.08–9.04) for RBP4 in the first trimester and 3.38 (1.03–11.08) for RBP4 in the second trimester. Conclusions Plasma RBP4 levels both in the first trimester and second trimester were dose-dependently associated with increased risk of GDM.


Placenta ◽  
2021 ◽  
Vol 112 ◽  
pp. e32-e33
Author(s):  
Daniela Mennickent ◽  
Andrés Rodríguez ◽  
Juan Araya ◽  
Enrique Guzmán-Gutiérrez

2016 ◽  
Vol 39 (5) ◽  
pp. 577-583 ◽  
Author(s):  
Hüsnü Alptekin ◽  
Ahmet Çizmecioğlu ◽  
Hatice Işık ◽  
Türkan Cengiz ◽  
Murat Yildiz ◽  
...  

Author(s):  
Xinmei Huang ◽  
Bingbing Zha ◽  
Manna Zhang ◽  
Yue Li ◽  
Yueyue Wu ◽  
...  

Abstract Objective The immune system plays a central role in the pathophysiology of gestational diabetes mellitus (GDM). Monocytes, the main innate immune cells, are especially important in the maintenance of a normal pregnancy. Here, we investigated the potential effect of monocytes in GDM. Materials and Methods: Monocyte count was monitored throughout pregnancy in 214 women with GDM and 926 women without in a case-control and cohort study. Circulating levels of inflammatory cytokines, placenta-derived macrophages and their products were measured. Results Throughout pregnancy, monocyte count was significantly decreased in women with GDM, and closely associated with glucose level, insulin resistance and newborn weight. First-trimester monocyte count outperformed that of the second and third trimester as a risk factor and diagnostic predictor of GDM and macrosomia in both the case-control and cohort study. In addition, our cohort study showed that as first-trimester monocyte count decreased, GDM and macrosomia incidence, glucose level and newborn weight increased in a stepwise manner. Risk of GDM started to decrease rapidly when first-trimester monocyte count exceeded 0.48 × 10 9/L. Notably, CD206 and IL-10 were significantly lower, while CD80, CD86, TNF-α and IL-6 were higher in both GDM placental tissue and peripheral blood. First-trimester monocyte count was positively related to IL-10 and CD206, but negatively related to CD80, CD86, TNF-α and IL-6. Conclusions Decreased monocyte count throughout pregnancy was closely-associated with the development of GDM, macrosomia and the chronic inflammatory state of GDM. First-trimester monocyte count has great potential as an early diagnostic marker of GDM.


Sign in / Sign up

Export Citation Format

Share Document